Loading...
TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy
BACKGROUND: Combination antiretroviral therapy results in metabolic abnormalities which increase cardiovascular disease risk. We evaluated whether telmisartan reduces insulin resistance in human immunodeficiency virus (HIV)–positive individuals on antiretrovirals. METHODS: We conducted a multicenter...
Na minha lista:
| Udgivet i: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201422/ https://ncbi.nlm.nih.gov/pubmed/31425580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz589 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|